Search Results 3491-3500 of 26351 for oral
About this study. This study will evaluate the efficacy of merimepodib (MMPD) administered orally every eight hours (q8h) for 10 days in adult patients with ...
The purpose of this study is to determine the safety and tolerability of orally administered NS-018 in patients with Primary Myelofibrosis (PMF), Post- ...
If subject is currently receiving an oral aminosalicylate, he or she is eligible and can stay on that dose of aminosalicylate provided the dose has been ...
Oral lesions. http://uptodate.com/home. Accessed Jan. 21, 2015. Wolff K, et al. Disorders of the mouth. In: Fitzpatrick's Color Atlas & Synopsis of Clinical ...
... orally twice daily (BID), or critozinib, 250 mg orally BID. Patients ... Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target ...
... oral anticoagulant 21. Comorbidities limiting life expectancy to less than one year 22. Subject is currently hospitalized for definite or suspected COVID-19
... oral corticosteroids within the previous 12 months. History of idiopathic ... Treatment with therapeutic oral or IV antibiotics within 2 weeks prior to initiation ...
... (oral, intravaginal, or transdermal);; Progestogen-only hormonal contraception associated with inhibition of ovulation (oral, injectable, implantable); ...
... oral GnRh antagonists, estrogens, or older antiandrogens are allowed but combinations of oral regimens only are not permitted). Patients who are anticipated ...
2h Post Glucose (PG) ≥ 200mg (11.1 mmol/L) during OGTT (oral glucose tolerance test); OR. Any (1) PDM present followed by an anti-diabetes medication ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
The challenge ends 10/10. Your gift today can have 5X the impact on AI research and technology.